Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 327,751 | 474,002 | 495,769 | 432,487 | 418,276 |
| Cost of Goods | 107,193 | 215,892 | 161,349 | 96,314 | 88,501 |
| Gross Profit | 220,558 | 258,110 | 334,420 | 336,173 | 329,775 |
| Operating Expenses | 666,258 | 306,048 | 638,608 | 251,408 | 219,056 |
| Operating Income | -445,507 | -47,046 | -303,839 | 85,079 | 111,220 |
| Interest Expense | 25,709 | 51,971 | 68,382 | 73,153 | 53,251 |
| Other Income | 4,713 | -30,668 | -8,186 | 3,338 | -18,125 |
| Pre-tax Income | -466,503 | -129,685 | -380,407 | 15,264 | 39,844 |
| Income Tax | -47 | 39,654 | -175,254 | 13,171 | 7,065 |
| Net Income Continuous | -466,456 | -169,339 | -205,153 | 2,093 | 32,779 |
| Net Income Discontinuous | N/A | 103,578 | 5,925 | -4,576 | N/A |
| Net Income | $-466,456 | $-65,761 | $-199,228 | $-2,483 | $32,779 |
| EPS Basic Total Ops | -13.71 | -1.91 | -5.71 | -0.07 | 1.04 |
| EPS Basic Continuous Ops | -13.71 | -4.92 | -5.88 | 0.06 | 1.04 |
| EPS Basic Discontinuous Ops | N/A | 3.01 | 0.17 | -0.13 | N/A |
| EPS Diluted Total Ops | -13.71 | -1.91 | -5.71 | -0.07 | 0.93 |
| EPS Diluted Continuous Ops | -13.71 | -4.92 | -5.88 | 0.06 | 0.93 |
| EPS Diluted Discontinuous Ops | N/A | 3.01 | 0.17 | -0.13 | N/A |
| EPS Diluted Before Non-Recurring Items | -6.88 | -3.88 | -5.71 | -0.07 | 0.93 |
| EBITDA(a) | $-403,036 | $140,922 | $-133,604 | $197,694 | $193,854 |